Monitoring G Protein-Coupled Receptor Activation Using the Protein Fragment Complementation Technique Split TEV
- 23 December 2015
- book chapter
- Published by Springer Nature
- Vol. 1272, 107-118
Abstract
G protein-coupled receptors (GPCRs) modulate cellular signaling, often in a ligand-specific manner. Cellular effects regulated include differentiation, proliferation, hormonal regulation, and neuronal activity. Further, they are involved in many disease-relevant processes, such as cancer and neurodevelopmental diseases, and represent the largest class of drug targets. Therefore, monitoring how GPCRs are regulated in their activity is crucial to understand their role in physiological processes and implications for drug development. Split TEV, a method based on TEV protease fragment complementation, can be used to sensitively assay GPCR activities in living cells. The activity of a given GPCR is monitored through its binding to β-arrestin. Split TEV reporters provide at minimum a two-step amplification process facilitating a flexible format and a robust readout. For the initial setup, a GPCR of interest and β-arrestin are fused to the N- and C-terminal fragments of the TEV protease, and occurred interactions are indicated by increased fluorescence or luminescence of TEV cleavage-dependent reporters. The experimental procedure takes 24–72 h to complete, depending on the cell type and complexity of the experimental setup applied.Keywords
This publication has 24 references indexed in Scilit:
- An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseasesBiotechnology Advances, 2013
- The GPCR Network: a large-scale collaboration to determine human GPCR structure and functionNature Reviews Drug Discovery, 2012
- Druggable Targets and Targeted Drugs: Enhancing the Development of New TherapeuticsPharmacology, 2008
- Structural diversity of G protein-coupled receptors and significance for drug discoveryNature Reviews Drug Discovery, 2008
- G-protein-coupled receptors and cancerNature Reviews Cancer, 2007
- When 7 transmembrane receptors are not G protein-coupled receptorsJournal of Clinical Investigation, 2005
- Quantitative Cell-Based High-Content Screening for Vasopressin Receptor Agonists Using Transfluor®TechnologySLAS Discovery, 2005
- High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based β-Arrestin2 Recruitment AssaySLAS Discovery, 2005
- Development of a BRET2 Screening Assay Using β-Arrestin 2 MutantsSLAS Discovery, 2004
- A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor ActivationJournal of Biological Chemistry, 1997